130 related articles for article (PubMed ID: 29027579)
1. DNA-methylation profiling discloses significant advantages over NanoString method for molecular classification of medulloblastoma.
Korshunov A; Chavez L; Northcott PA; Sharma T; Ryzhova M; Jones DTW; von Deimling A; Pfister SM; Kool M
Acta Neuropathol; 2017 Dec; 134(6):965-967. PubMed ID: 29027579
[No Abstract] [Full Text] [Related]
2. Circular RNA profiling distinguishes medulloblastoma groups and shows aberrant RMST overexpression in WNT medulloblastoma.
Rickert D; Bartl J; Picard D; Bernardi F; Qin N; Lovino M; Puget S; Meyer FD; Mahoungou Koumba I; Beez T; Varlet P; Dufour C; Fischer U; Borkhardt A; Reifenberger G; Ayrault O; Remke M
Acta Neuropathol; 2021 Jun; 141(6):975-978. PubMed ID: 33866410
[No Abstract] [Full Text] [Related]
3. Approach to molecular subgrouping of medulloblastomas: Comparison of NanoString nCounter assay versus combination of immunohistochemistry and fluorescence in-situ hybridization in resource constrained centres.
Kaur K; Jha P; Pathak P; Suri V; Sharma MC; Garg A; Suri A; Sarkar C
J Neurooncol; 2019 Jul; 143(3):393-403. PubMed ID: 31104222
[TBL] [Abstract][Full Text] [Related]
4. Medulloblastoma: Molecular Classification-Based Personal Therapeutics.
Archer TC; Mahoney EL; Pomeroy SL
Neurotherapeutics; 2017 Apr; 14(2):265-273. PubMed ID: 28386677
[TBL] [Abstract][Full Text] [Related]
5. TERT promoter mutation and aberrant hypermethylation are associated with elevated expression in medulloblastoma and characterise the majority of non-infant SHH subgroup tumours.
Lindsey JC; Schwalbe EC; Potluri S; Bailey S; Williamson D; Clifford SC
Acta Neuropathol; 2014 Feb; 127(2):307-9. PubMed ID: 24337442
[No Abstract] [Full Text] [Related]
6. Robust molecular subgrouping and copy-number profiling of medulloblastoma from small amounts of archival tumour material using high-density DNA methylation arrays.
Hovestadt V; Remke M; Kool M; Pietsch T; Northcott PA; Fischer R; Cavalli FM; Ramaswamy V; Zapatka M; Reifenberger G; Rutkowski S; Schick M; Bewerunge-Hudler M; Korshunov A; Lichter P; Taylor MD; Pfister SM; Jones DT
Acta Neuropathol; 2013 Jun; 125(6):913-6. PubMed ID: 23670100
[No Abstract] [Full Text] [Related]
7. DNA methylation profiling of medulloblastoma allows robust subclassification and improved outcome prediction using formalin-fixed biopsies.
Schwalbe EC; Williamson D; Lindsey JC; Hamilton D; Ryan SL; Megahed H; Garami M; Hauser P; Dembowska-Baginska B; Perek D; Northcott PA; Taylor MD; Taylor RE; Ellison DW; Bailey S; Clifford SC
Acta Neuropathol; 2013 Mar; 125(3):359-71. PubMed ID: 23291781
[TBL] [Abstract][Full Text] [Related]
8. Intertumoral and intratumoral heterogeneity as a barrier for effective treatment of medulloblastoma.
Wang X; Ramaswamy V; Remke M; Mack SC; Dubuc AM; Northcott PA; Taylor MD
Neurosurgery; 2013 Aug; 60 Suppl 1():57-63. PubMed ID: 23839353
[No Abstract] [Full Text] [Related]
9. [Risk stratification in medulloblastoma: screening for molecular markers].
Ebinger M; Senf L; Scheurlen W
Klin Padiatr; 2006; 218(3):139-42. PubMed ID: 16688669
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic Accuracy of a Reduced Immunohistochemical Panel in Medulloblastoma Molecular Subtyping, Correlated to DNA-methylation Analysis.
Tauziède-Espariat A; Huybrechts S; Indersie E; Dufour C; Puget S; Chivet A; Roux A; Pagès M; Gareton A; Chrétien F; Lechapt E; Ayrault O; Varlet P
Am J Surg Pathol; 2021 Apr; 45(4):558-566. PubMed ID: 33323893
[TBL] [Abstract][Full Text] [Related]
11. A transcriptome-based classifier to determine molecular subtypes in medulloblastoma.
Rathi KS; Arif S; Koptyra M; Naqvi AS; Taylor DM; Storm PB; Resnick AC; Rokita JL; Raman P
PLoS Comput Biol; 2020 Oct; 16(10):e1008263. PubMed ID: 33119584
[TBL] [Abstract][Full Text] [Related]
12. Array-based profiling of reference-independent methylation status (aPRIMES) identifies frequent promoter methylation and consecutive downregulation of ZIC2 in pediatric medulloblastoma.
Pfister S; Schlaeger C; Mendrzyk F; Wittmann A; Benner A; Kulozik A; Scheurlen W; Radlwimmer B; Lichter P
Nucleic Acids Res; 2007; 35(7):e51. PubMed ID: 17344319
[TBL] [Abstract][Full Text] [Related]
13. Rapid, reliable, and reproducible molecular sub-grouping of clinical medulloblastoma samples.
Northcott PA; Shih DJ; Remke M; Cho YJ; Kool M; Hawkins C; Eberhart CG; Dubuc A; Guettouche T; Cardentey Y; Bouffet E; Pomeroy SL; Marra M; Malkin D; Rutka JT; Korshunov A; Pfister S; Taylor MD
Acta Neuropathol; 2012 Apr; 123(4):615-26. PubMed ID: 22057785
[TBL] [Abstract][Full Text] [Related]
14. Subgroup-specific structural variation across 1,000 medulloblastoma genomes.
Northcott PA; Shih DJ; Peacock J; Garzia L; Morrissy AS; Zichner T; Stütz AM; Korshunov A; Reimand J; Schumacher SE; Beroukhim R; Ellison DW; Marshall CR; Lionel AC; Mack S; Dubuc A; Yao Y; Ramaswamy V; Luu B; Rolider A; Cavalli FM; Wang X; Remke M; Wu X; Chiu RY; Chu A; Chuah E; Corbett RD; Hoad GR; Jackman SD; Li Y; Lo A; Mungall KL; Nip KM; Qian JQ; Raymond AG; Thiessen NT; Varhol RJ; Birol I; Moore RA; Mungall AJ; Holt R; Kawauchi D; Roussel MF; Kool M; Jones DT; Witt H; Fernandez-L A; Kenney AM; Wechsler-Reya RJ; Dirks P; Aviv T; Grajkowska WA; Perek-Polnik M; Haberler CC; Delattre O; Reynaud SS; Doz FF; Pernet-Fattet SS; Cho BK; Kim SK; Wang KC; Scheurlen W; Eberhart CG; Fèvre-Montange M; Jouvet A; Pollack IF; Fan X; Muraszko KM; Gillespie GY; Di Rocco C; Massimi L; Michiels EM; Kloosterhof NK; French PJ; Kros JM; Olson JM; Ellenbogen RG; Zitterbart K; Kren L; Thompson RC; Cooper MK; Lach B; McLendon RE; Bigner DD; Fontebasso A; Albrecht S; Jabado N; Lindsey JC; Bailey S; Gupta N; Weiss WA; Bognár L; Klekner A; Van Meter TE; Kumabe T; Tominaga T; Elbabaa SK; Leonard JR; Rubin JB; Liau LM; Van Meir EG; Fouladi M; Nakamura H; Cinalli G; Garami M; Hauser P; Saad AG; Iolascon A; Jung S; Carlotti CG; Vibhakar R; Ra YS; Robinson S; Zollo M; Faria CC; Chan JA; Levy ML; Sorensen PH; Meyerson M; Pomeroy SL; Cho YJ; Bader GD; Tabori U; Hawkins CE; Bouffet E; Scherer SW; Rutka JT; Malkin D; Clifford SC; Jones SJ; Korbel JO; Pfister SM; Marra MA; Taylor MD
Nature; 2012 Aug; 488(7409):49-56. PubMed ID: 22832581
[TBL] [Abstract][Full Text] [Related]
15. Medulloblastoma: a potpourri of distinct entities.
Pfister S
Acta Neuropathol; 2012 Apr; 123(4):463-4. PubMed ID: 22392443
[No Abstract] [Full Text] [Related]
16. Childhood medulloblastoma: novel approaches to the classification of a heterogeneous disease.
Ellison DW
Acta Neuropathol; 2010 Sep; 120(3):305-16. PubMed ID: 20652577
[TBL] [Abstract][Full Text] [Related]
17. Intercellular heterogeneity of expression of the MGMT DNA repair gene in pediatric medulloblastoma.
Rood BR; Zhang H; Cogen PH
Neuro Oncol; 2004 Jul; 6(3):200-7. PubMed ID: 15279712
[TBL] [Abstract][Full Text] [Related]
18. [Subtypes of medulloblastomas: distinct cellular origins].
Bourdeaut F; Pouponnot C; Ayrault O
Med Sci (Paris); 2012 Oct; 28(10):805-9. PubMed ID: 23067406
[No Abstract] [Full Text] [Related]
19. Molecular Classification of Medulloblastoma.
Kijima N; Kanemura Y
Neurol Med Chir (Tokyo); 2016 Nov; 56(11):687-697. PubMed ID: 27238212
[TBL] [Abstract][Full Text] [Related]
20. What's new in neuro-oncology? Recent advances in medulloblastoma.
Ellison DW; Clifford SC; Gajjar A; Gilbertson RJ
Eur J Paediatr Neurol; 2003; 7(2):53-66. PubMed ID: 12697428
[No Abstract] [Full Text] [Related]
[Next] [New Search]
